Abstract
A 79-year-old woman was referred to our hospital because numerous polyps were found in her stomach and large intestine at an ambulatory clinic. Although there were no characteristic symptoms or signs of Cronkhite-Canada syndrome (CCS), endoscopic and pathological findings indicated CCS. Moreover, colonoscopy showed two polypoid lesions (Is type), which appeared neoplastic by magnifying observation with image-enhanced endoscopy (IEE), in the ascending colon. Histologically, the resected specimens revealed tubular adenomas arising in the CCS inflammatory polyps. Remarkable remission of the polyps and edematous mucosa in the stomach and colon was seen after 8 months of administration of salazosulfapyridine (SASP) (3 g/day). Another adenoma was detected and removed endoscopically in the sigmoid colon. This is the first report to describe an asymptomatic case of CCS probably detected in the early phase of the disease, by magnifying IEE which enabled detection and treatment for associated colonic adenomas. SASP was effective in eradication of the inflammatory polyposis, and an additional adenoma was successfully found and removed by surveillance colonoscopy thereafter.
References
Cronkhite LW Jr, Canada WJ (1955) Generalized gastrointestinal polyposis. An unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 252:1011–1015
Daniel ES, Ludwig SL, Lewin KJ, Ruprecht RM, Rajacich GM, Schwabe AD (1982) The Cronkhite-Canada syndrome: an analysis of clinical and pathologic features and therapy in 55 patients. Medicine 47:504–510
Parsa C (1982) Cronkhite-Canada syndrome associated with systemic vasculitis: an autopsy study. Hum Pathol 13:758–760
Malhotra R, Sheffield A (1988) Cronkhite-Canada syndrome with colon carcinoma and adenomatous changes in C–C polyps. Am J Gastroenterol 183:772–776
Yashiro M, Kobayashi H, Kubo N, Nishiguchi Y, Wakasa K, Hirakawa K (2004) Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion 69:57–62
Saeki T, Yokoyama H, Fukuda T et al (1995) Cronkhite-Canada syndrome associated with sigmoid colon cancer. Jpn J Cancer Clin 41:1233–1239
Nagata J, Kijima H, Hasumi K, Suzuki T, Shirai T, Mine T (2003) Adenocarcinoma and multiple adenomas of the large intestine, associated with Cronkhite-Canada syndrome. Dig Liver Dis 35:434–438
Jain A, Nanda S, Chakraborty P et al (2003) Cronkhite-Canada syndrome with adenomatous and carcinomatous transformation of colonic polyp. Indian J Gastroenterol 22:189–190
Yamashita T, Miyazawa M, Suzuki H (1996) A case of Cronkhite-Canada syndrome improved markedly with antiplasmin agent and steroid. Gastroenterol Endosc 38:45–50
Okamoto K, Isomoto H, Shikuwa S, Nishiyama H, Ito M, Kohno S (2008) A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion 78:82–87
Koishi T (1976) A case of Cronkhite-Canada syndrome. Nippon Naika Gakkai Zasshi J Jpn Soc Int Med 65:1060
Goto A, Shibuya C, Matsunami E (1984) Cronkhite-Canada syndrome. Shokaki Geka 15:111–143 (Seminar)
Kojima E, Tomita A, Matsumura M, Kinoshita M (2009) Magnifying the endoscopic appearance of Cronkhite-Canada syndrome. Gastrointest Endosc 70:1242–1243
Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7–G17
Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107:117–120
Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451–459
Gupta RB, Harpaz N, Itzkowitz S et al (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133:1099–1105
Prantera C, Viscido A, Biancone L, Francavilla A, Giglio L, Campieri M (2005) A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis 11:421–427
D’Haens G, Hommes D, Engels L et al (2006) Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study. Aliment Pharmacol Ther 24:1087–1097
Prantera C, Rizzi M (2009) 5-ASA in ulcerative colitis: improving treatment compliance. World J Gastroenterol 21:4353–4355
Suzuki R, Irisawa A, Hikichi T et al (2009) Cronkhite-Canada syndrome associated with myelodysplastic syndrome. World J Gastroenterol 14:5871–5874
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ueyama, H., Fu, K., Ogura, K. et al. Successful treatment for Cronkhite-Canada syndrome with endoscopic mucosal resection and salazosulfapyridine. Tech Coloproctol 18, 503–507 (2014). https://doi.org/10.1007/s10151-012-0863-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-012-0863-0